Simcere Pharma (02096) has disclosed that it spent approximately HK$10.70 million to repurchase 929,000 shares on September 9.
According to a company announcement, the share buyback was executed at a total cost of HK$10.7033 million on that date.
Simcere Pharma (02096) has disclosed that it spent approximately HK$10.70 million to repurchase 929,000 shares on September 9.
According to a company announcement, the share buyback was executed at a total cost of HK$10.7033 million on that date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.